Insurtech investment jumps 155% YOY in Q1

Insurtech investment volume jumped 155 percent year on year to $724 million in the first quarter of 2018, according to research by Willis Towers Watson.

Compared to the fourth quarter of 2017, insurtech investment volume was up 16 percent.

Investment deals marked a new high in the first quarter of 2018 with 66 insurtech transactions. Deal sizes continued to increase and the line between insurtech funding by incumbent re/insurers and traditional venture capital was blurred by newer “hybrid” investment funds, according to the latest Quarterly InsurTech Briefing.

Seven $30+ million investment rounds were completed during the first quarter. Investors continued to make increased bets in selected companies. The briefing finds that insurance sector incumbents prefer minority investments in startups developing technology which will ease their own commercial pressure points, including distribution costs, claims handling, and underwriting excellence. They seek improved processes and focus on nodes within the value chain that present the biggest challenges. Achieving an outsized investment return is secondary to incumbent investors.

In contrast, traditional venture capital (VC) investors tend to focus on insurtechs which address customer pressure points such as price, ease of access, and underserved markets through innovation. They tend to be product and not process focused and look to developments in other sectors for ideas.

Unlike incumbent re/insurers, traditional VC insurtech capital is likely to take majority positions and focus on integration across the industry value chain. Traditional VCs are solely driven by investment return. However, they often lack meaningful access to the insurance market, and therefore tend to pursue revolutionary ideas, according to the briefing.

As insurtech investment surges, companies are finding a third way. A subset of specialist insurance investors is creating a “hybrid” model in which they seek to blend the best of both traditional and incumbent re/insurer venture capital models. These “hybrid” models are looking to combine the traditional VC investor mentality with the industry expertise of incumbents to create a more aligned model that targets both financial and strategic returns for its investors.

Rafal Walkiewicz, CEO, Willis Towers Watson Securities, said: “For insurtech startups, the funding scene is more complex, and finding the right investment partner has become more difficult. Hybrid models will continue to evolve and may be the ultimate answer for insurtech entrepreneurs looking to balance industry expertise and the traditional VC value-creation mentality.”

Paddy Jago, global chairman of Willis Re, said: “The incumbent market has actually been relatively receptive to taking a serious look at the digital innovation that is going on around us, and those driving it. Most of us know that to remain relevant, we need to embrace change. I have always believed that we cannot view change and not change ourselves.”

Make sure you are GDPR compliant and  confirm your email address to keep getting our daily emails

More of today's news

Amtrust launches attempt to win over investors in go-private deal

Lloyd’s Brussels unit gets regulatory approval with Vandendael as CEO

Corporate insurance faces ‘radical’ change

IUA forms new cyber reinsurance group

Neon appoints group underwriting director from Ascot

Ardonagh Q1 adjusted EBITDA climbs 12.7%

AM Best identifies re/insurers’ GDPR challenges

Don't miss our insurtech email newsletter - sign up today